These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 18345954)

  • 1. Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.
    Macfarlane RJ; Ng BH; Gamie Z; El Masry MA; Velonis S; Schizas C; Tsiridis E
    Expert Opin Pharmacother; 2008 Apr; 9(5):767-86. PubMed ID: 18345954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
    Nilsson OS
    Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].
    Zouhair A; Ozsahin M; Mouhsine E; Leyvraz PF; Mirimanoff RO; Coucke PA
    Schweiz Med Wochenschr; 1999 Mar; 129(9):370-6. PubMed ID: 10198948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotopic ossification following total hip arthroplasty: a review.
    Hu HP; Slooff TJ; van Horn JR
    Acta Orthop Belg; 1991; 57(2):169-82. PubMed ID: 1908171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P; Schmidt SA
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No migration of acetabular cups after prophylaxis for heterotopic ossification.
    Ince A; Sauer U; Wollmerstedt N; Hendrich C
    Clin Orthop Relat Res; 2007 Aug; 461():125-9. PubMed ID: 17415004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty.
    Board TN; Karva A; Board RE; Gambhir AK; Porter ML
    J Bone Joint Surg Br; 2007 Apr; 89(4):434-40. PubMed ID: 17463108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
    Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
    Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
    Koelbl O; Seufert J; Pohl F; Tauscher A; Lehmann H; Springorum HW; Flentje M
    Strahlenther Onkol; 2003 Nov; 179(11):767-73. PubMed ID: 14605747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial.
    Saudan M; Saudan P; Perneger T; Riand N; Keller A; Hoffmeyer P
    J Bone Joint Surg Br; 2007 Feb; 89(2):155-9. PubMed ID: 17322426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotopic ossification in patients after total hip replacement.
    Stołtny T; Koczy B; Wawrzynek W; Miszczyk L
    Ortop Traumatol Rehabil; 2007; 9(3):264-72. PubMed ID: 17721424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum.
    Karunakar MA; Sen A; Bosse MJ; Sims SH; Goulet JA; Kellam JF
    J Bone Joint Surg Br; 2006 Dec; 88(12):1613-7. PubMed ID: 17159174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of heterotopic ossification following hip surgery: an update.
    Pavlou G; Kyrkos M; Tsialogiannis E; Korres N; Tsiridis E
    Expert Opin Pharmacother; 2012 Apr; 13(5):619-22. PubMed ID: 22404455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG; Schmidt M; Wanivenhaus A
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to routine use of pharmacological prophylaxis of heterotopic ossification after total hip arthroplasty: results from an Italian multicenter, prospective, observational survey.
    Barbato M; D'Angelo E; Di Loreto G; Menna A; Di Francesco A; Salini V; Zoppi U; Cavasinni L; La Floresta P; Romanò CL
    J Orthop Traumatol; 2012 Jun; 13(2):63-7. PubMed ID: 22358779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
    Romanò CL; Duci D; Romanò D; Mazza M; Meani E
    J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib and heterotopic bone formation after total hip arthroplasty.
    Lavernia CJ; Contreras JS; Villa JM; Rossi MD
    J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy as prevention of heterotopic ossification--preliminary results].
    Miszczyk L; Spindel J; Maciejewski B; Walichiewicz P; Tarnawski R; Horzela A; Woźniak G
    Przegl Lek; 2004; 61(2):61-4. PubMed ID: 15230142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive update on the pharmacological management of heterotopic ossification following hip arthroplasty: a level I evidenced based expert opinion.
    Migliorini F; Asparago G; Oliva F; Cuozzo F; Maffulli N
    Expert Opin Pharmacother; 2022 Jul; 23(10):1195-1203. PubMed ID: 35698796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.